NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 54 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $51,000 | +34.2% | 367,700 | 0.0% | 0.00% | – |
| Q4 2018 | $38,000 | -55.3% | 367,700 | 0.0% | 0.00% | – |
| Q3 2018 | $85,000 | +1.2% | 367,700 | 0.0% | 0.00% | – |
| Q2 2018 | $84,000 | -36.4% | 367,700 | 0.0% | 0.00% | – |
| Q1 2018 | $132,000 | 0.0% | 367,700 | 0.0% | 0.00% | – |
| Q4 2017 | $132,000 | -13.7% | 367,700 | 0.0% | 0.00% | – |
| Q3 2017 | $153,000 | -18.6% | 367,700 | 0.0% | 0.00% | – |
| Q2 2017 | $188,000 | -11.3% | 367,700 | 0.0% | 0.00% | – |
| Q1 2017 | $212,000 | -8.2% | 367,700 | 0.0% | 0.00% | – |
| Q4 2016 | $231,000 | -31.5% | 367,700 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $337,000 | +72.8% | 367,700 | 0.0% | 0.00% | – |
| Q2 2016 | $195,000 | -43.8% | 367,700 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $347,000 | -29.0% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $489,000 | -41.6% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $838,000 | +41.6% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $592,000 | -6.9% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $636,000 | 0.0% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $636,000 | +31.1% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $485,000 | -10.8% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $544,000 | -13.0% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $625,000 | -16.2% | 367,700 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $746,000 | -24.4% | 367,700 | -1.3% | 0.00% | -50.0% |
| Q3 2013 | $987,000 | +12.4% | 372,600 | +13.3% | 0.00% | 0.0% |
| Q2 2013 | $878,000 | – | 328,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|